AMN

DALLAS, July 7, 2026 /PRNewswire/ -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its second quarter 2026 financial results and third quarter 2026 outlook on Thursday, August 6, 2026, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time. A live webcast of the call can be accessed through this webcast link, which also will be available on AMN Healthcare's investor relations website. Interested parties may participate live via telephone by registering at this conference call link. Please follow the link and register with a valid e-mail address. After registering, the system will call you instantly and connect you into the conference call automatically. Alternatively, you may dial in to the conference call by calling 1-646-357-8785 or 1-800-836-8184 and you will be connected to the call by an operator. Following the conclusion of the call, a replay of the webcast will be available at the Company's investor relations website, http://ir.amnhealthcare.com. About AMN Healthcare AMN Healthcare is the leader and innovator in total talent solutions for healthcare, bringing together the people, processes and technology to deliver better care. Through a steadfast partnership approach, we solve the most pressing workforce challenges to enable better clinical outcomes and access to care. In 2025, our healthcare professionals reached more than 13 million patients at more than 2,300 healthcare systems, including 93 percent of the top healthcare systems nationwide. We provide a comprehensive network of quality healthcare professionals and deliver a fully integrated and customizable suite of workforce technologies. For more information, visit www.amnhealthcare.com. The Company's common stock is listed under the symbol "AMN" on the New York Stock Exchange. For more information about AMN Healthcare, visit www.amnhealthcare.com, where the Company posts news releases, investor presentations, webcasts, SEC filings and other material information. The Company also utilizes email alerts and Really Simple Syndication ("RSS") as routine channels to supplement the distribution of this information. To register for email alerts and RSS, visit http://ir.amnhealthcare.com. Contact:Randle ReeceVice President, Investor Relations and Strategy866-...

AMN Healthcare Services recently presented at the 46th Annual William Blair Growth Stock Conference in Chicago, highlighting the company’s latest developments to investors and analysts. Its strong Q1 2026 earnings, with improvements in revenue, EBITDA and earnings per share, have reinforced growing institutional interest and confidence in the business. We’ll now examine how AMN Healthcare’s recent earnings strength and institutional enthusiasm could shape the company’s investment narrative going forward. We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them. For AMN Healthcare, the big picture an investor needs to buy into is a company working through a messy earnings and governance reset while trying to prove its staffing platforms and technology can support consistent profitability again. The strong Q1 2026 beat, coming after a period of losses, has clearly helped sentiment, as reflected in the sharp year-to-date share price move and the bullish tone around the William Blair conference appearance. In the near term, the key catalysts now look like sustained margin improvement against the relatively soft Q2 margin guidance, and how effectively the refreshed board, including Eric Palmer, can influence capital allocation and operational discipline. At the same time, the failed independent chair proposal and still-weak return on equity keep governance and execution risk firmly on the table. However, this improving story sits alongside governance questions that investors should not ignore. AMN Healthcare Services' shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be. The single US$31.62 fair value estimate from the Simply Wall St Community lines up closely with prior cash flow based work, yet recent earnings volatility and governance frictions remind you that community and institutional views can diverge sharply, so it is worth comparing several perspectives before deciding how AMN’s recovery potential fits your own expectations. Explore another fair value estimate on AMN Healthcare Services - why the stock might be worth just $31.62! Don't just follow the ticker - dig into the data and build a conviction that's truly your own. A great starting point for your AMN Healthcare Services research is our analysis highlighting 2 key rewards that could...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at AMN Healthcare Services (NYSE:AMN) and the best and worst performers in the healthcare providers & services industry. The healthcare providers and services sector, from insurers to hospitals, benefits from consistent demand, generating stable revenue through premiums and patient services. However, it faces challenges from high operational and labor costs, reimbursement pressures that squeeze margins, and regulatory uncertainty. Looking ahead, an aging population with more chronic diseases and a shift toward value-based care create tailwinds. Digitization via telehealth, data analytics, and personalized medicine offers new revenue streams. Nonetheless, headwinds persist, including clinical labor shortages, ongoing reimbursement cuts, and regulatory scrutiny over pricing and quality. The 40 healthcare providers & services stocks we track reported a strong Q1. As a group, revenues beat analysts’ consensus estimates by 1.4% while next quarter’s revenue guidance was in line. Luckily, healthcare providers & services stocks have performed well with share prices up 10.5% on average since the latest earnings results. With a network of thousands of healthcare professionals ranging from nurses to physicians to executives, AMN Healthcare (NYSE:AMN) provides healthcare workforce solutions including temporary staffing, permanent placement, and technology platforms for hospitals and healthcare facilities across the United States. AMN Healthcare Services reported revenues of $1.38 billion, up 99.9% year on year. This print exceeded analysts’ expectations by 11.8%. Overall, it was an exceptional quarter for the company with a beat of analysts’ EPS and revenue estimates. “Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment,” said Cary Grace, President and Chief Executive Officer of AMN Healthcare. AMN Healthcare Services pulled off the biggest analyst estimate beat and fastest revenue growth of the whole group. Unsurprisingly, the stock is up 31.2% since reporting and currently trades at $29.46. Is now the time to buy AMN Healthcare Services? Access our full analysis of the earnings results here, it’s fre...

AMN Healthcare Services’ first quarter was marked by rapid scaling to support several large labor disruption events, a factor management described as a major operational milestone. CEO Caroline Grace credited the company’s technology investments and clinician network for enabling AMN to respond quickly and deliver high-touch service during these disruptions. She emphasized, “Our ability to move thousands of clinicians to meet urgent needs delivered great value on a scale we could not have done just a few years ago.” Management also highlighted improved performance in the core Nurse and Allied Staffing divisions, with the international staffing business returning to year-over-year growth. Is now the time to buy AMN? Find out in our full research report (it’s free). Revenue: $1.38 billion vs analyst estimates of $1.23 billion (99.9% year-on-year growth, 11.8% beat) Adjusted EPS: $2.10 vs analyst estimates of $1.62 (29.9% beat) Adjusted EBITDA: $166.1 million vs analyst estimates of $122.6 million (12.1% margin, 35.5% beat) Revenue Guidance for Q2 CY2026 is $627.5 million at the midpoint, below analyst estimates of $635.6 million Operating Margin: 8.5%, up from 1.8% in the same quarter last year Sales Volumes rose 2.7% year on year (-22.1% in the same quarter last year) Market Capitalization: $1.20 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Melissa (William Blair) asked about normalization in contract labor fill rates post-pandemic. CEO Caroline Grace explained that client conversations have shifted from reducing contract labor to pursuing sustainable total workforce solutions, emphasizing predictive analytics and talent optimization. Melissa (William Blair) followed up on whether labor disruption events are deepening client relationships and creating future revenue opportunities. Grace confirmed that supporting clients through crisis events has strengthened relationships and is expected to drive future business. Jeffrey Silber (BMO Capital Markets) inquired about the difference between rapid response and labor disruption revenues. CFO Brian Scott clarified that rapid response assignments are shorter and h...

Healthcare staffing company AMN Healthcare Services (NYSE:AMN) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 99.9% year on year to $1.38 billion. On the other hand, next quarter’s revenue guidance of $627.5 million was less impressive, coming in 1.3% below analysts’ estimates. Its non-GAAP profit of $2.10 per share was 29.9% above analysts’ consensus estimates. Is now the time to buy AMN? Find out in our full research report (it’s free). Revenue: $1.38 billion vs analyst estimates of $1.23 billion (99.9% year-on-year growth, 11.8% beat) Adjusted EPS: $2.10 vs analyst estimates of $1.62 (29.9% beat) Adjusted EBITDA: $166.1 million vs analyst estimates of $122.6 million (12.1% margin, 35.5% beat) Revenue Guidance for Q2 CY2026 is $627.5 million at the midpoint, below analyst estimates of $635.6 million Operating Margin: 8.5%, up from 1.8% in the same quarter last year Sales Volumes rose 2.7% year on year (-22.1% in the same quarter last year) Market Capitalization: $867.8 million AMN Healthcare Services’ first quarter was marked by rapid scaling to support several large labor disruption events, a factor management described as a major operational milestone. CEO Caroline Grace credited the company’s technology investments and clinician network for enabling AMN to respond quickly and deliver high-touch service during these disruptions. She emphasized, “Our ability to move thousands of clinicians to meet urgent needs delivered great value on a scale we could not have done just a few years ago.” Management also highlighted improved performance in the core Nurse and Allied Staffing divisions, with the international staffing business returning to year-over-year growth. Looking forward, AMN’s guidance reflects a normalization of revenue following the extraordinary impact of labor disruption events in the first quarter. Management expects ongoing investments in technology, workforce solutions, and operational efficiency to support the company’s transition toward more sustainable long-term growth. CFO Brian Scott noted, “We remain confident that we have the team and strategy to deliver leading tech-enabled solutions that will drive sustainable revenue growth with improved operating leverage.” The company is focused on expanding client relationships, leveraging AI tools, and driving cost discipline to navigate a more stable demand environment. Mana...

In the first quarter of 2026, AMN Healthcare Services reported sales of US$1.38 billion and net income of US$62.17 million, reversing a prior-year loss and delivering basic earnings per share from continuing operations of US$1.60. This performance was heavily influenced by revenue from multiple large labor disruption events, highlighting how temporary strike-related demand can significantly reshape AMN’s quarterly mix and profitability. We’ll now examine how this labor-disruption-fueled earnings beat may affect AMN Healthcare’s investment narrative built around flexible staffing and technology. Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research. To own AMN Healthcare, you need to believe that flexible, tech-enabled staffing and labor disruption support can offset pressure from hospitals tightening labor budgets and shifting toward internal staffing solutions. Q1 2026’s strike-driven upside sharpens that debate in the near term, while the biggest near-term risk is how sharply revenue and margins step down as disruption work fades and hospitals continue to push back on premium bill rates. The Q2 2026 guidance looks most relevant here: AMN is projecting consolidated revenue of US$620 million to US$635 million and an operating margin around breakeven. That wide reset from Q1’s US$1.38 billion and positive profitability underlines how dependent recent results were on one-off disruption activity, and keeps the core questions about pricing pressure and hospital cost containment front and center for the stock’s short term setup. But investors should also be aware of how tighter hospital labor budgets and ongoing pricing pressure could... Read the full narrative on AMN Healthcare Services (it's free!) AMN Healthcare Services' narrative projects $2.8 billion revenue and $142.4 million earnings by 2029. This implies fairly flat yearly revenue growth and a $238.1 million earnings increase from -$95.7 million today. Uncover how AMN Healthcare Services' forecasts yield a $22.21 fair value, a 27% downside to its current price. Before this Q1 surprise, the most optimistic analysts were already assuming about US$2.7 billion of 2028 revenue and a slim US$5.3 million profit, so you can see how opinions differ and why this disr...

AMN Healthcare Services, Inc. AMN delivered adjusted earnings per share (EPS) of $2.10 in the first-quarter 2026, up 367% year over year. The figure surpassed the Zacks Consensus Estimate by 31.3%. GAAP EPS for the quarter was $1.59 against a loss per share of 3 cents in the year-ago period. AMN Healthcare registered revenues of $1.38 billion in the first quarter, up 100% year over year. The figure surpassed the Zacks Consensus Estimate by 11.9%. Shares of this company gained nearly 3.1% in yesterday’s after-hours trading. The company’s shares have rallied 44.8% in the year-to-date period against the industry’s decline of 13.1%. However, the S&P 500 Index has increased 8.5% in the same time frame. Image Source: Zacks Investment Research AMN Healthcare conducts its business via three reportable segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. In the first quarter of 2026, the Nurse and Allied Solutions segment’s revenues totaled $1.13 billion, up 173% year over year. Travel nurse staffing revenues were up 12% year over year, whereas Allied revenues increased 3% year over year. Labor disruption events contributed $722 million in revenues in the quarter. The Zacks Consensus Estimate was pegged at $984 million. The Physician and Leadership Solutions segment’s revenues totaled $163.9 million, down 6% year over year. Locum tenens revenues were $131 million in the quarter, down 7% year over year. Interim leadership revenues were down 4% year over year. Physician and leadership search businesses saw a revenue increase of 4% year over year. The Zacks Consensus Estimate was pegged at $163 million. The Technology and Workforce Solutions segment’s revenues totaled $87.1 million, down 15% year over year. Language interpretation services business revenues came in at $69 million in the quarter, down 8% year over year, while the vendor management systems business saw an 18% year-over-year revenue decline to reach $16 million. The Zacks Consensus Estimate was pegged at $85 million. In the quarter under review, AMN Healthcare’s gross profit increased 86.2% year over year to $368.8 million. The gross margin contracted 190 basis points (bps) to 26.8%. Selling, general & administrative expenses fell 47.8% year over year to $218.4 million. Operating profit totaled $117.2 million, reflecting an increase of 836.8% fro...

AMN Healthcare Services (AMN) reported $1.38 billion in revenue for the quarter ended March 2026, representing a year-over-year increase of 99.9%. EPS of $2.10 for the same period compares to $0.45 a year ago. The reported revenue compares to the Zacks Consensus Estimate of $1.23 billion, representing a surprise of +11.9%. The company delivered an EPS surprise of +30.98%, with the consensus EPS estimate being $1.60. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health. Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. Here is how AMN Healthcare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Physician and leadership solutions: $163.92 million versus $163.01 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -5.8% change. Revenue- Nurse and allied solutions: $1.13 billion versus $984.24 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +172.8% change. Revenue- Technology and workforce solutions: $87.1 million compared to the $84.69 million average estimate based on two analysts. The reported number represents a change of -14.8% year over year. Segment operating income- Nurse and allied solutions: $153.33 million compared to the $97.77 million average estimate based on two analysts. Segment operating income- Technology and workforce solutions: $25.27 million versus $25.71 million estimated by two analysts on average. Segment operating income- Physician and leadership solutions: $10.82 million versus $13.62 million estimated by two analysts on average. View all Key Company Metrics for AMN Healthcare here>>> Shares of AMN Healthcare have returned +10.5% over the past month versus the Zacks S&P 500 composite's +11.4% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can...

DALLAS (AP) — DALLAS (AP) — AMN Healthcare Services Inc. (AMN) on Thursday reported first-quarter net income of $62.2 million, after reporting a loss in the same period a year earlier. The Dallas-based company said it had profit of $1.59 per share. Earnings, adjusted for non-recurring costs, were $2.10 per share. The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.60 per share. The health care staffing company posted revenue of $1.38 billion in the period. AMN Healthcare shares have risen 43% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $22.55, an increase of 15% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AMN at https://www.zacks.com/ap/AMN

Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Delivered Nurse and Allied revenue of $1.13 billion, which included $722 million from supporting five labor disruption events (including two of historic indefinite duration) and exceeded guidance by $122 million. Achieved year-over-year growth in traveler volume (excluding disruptions) for the first time since 2022, signaling a stabilization in core nursing demand. Successfully validated technology investments in AI recruitment and event management systems, deploying over 10,000 clinicians via the AI recruiter in Q1. International staffing returned to year-over-year growth for the first time since the fourth quarter of 2023, which was shortly after the State Department implemented Visa retrogression. Physician and Leadership Solutions faced headwinds as clients focused on centralizing program management and permanent hiring to manage costs. Language services began a strategic pivot to a tiered service model, utilizing more offshore resources and client-owned devices to improve margins. Client conversations have shifted from pandemic-era cost reduction to long-term 'total talent' strategies, focusing on predictive analytics and workforce sustainability. Q2 guidance assumes a normalization of bill rates in the Nurse and Allied segment as high-margin rapid response revenue from Q1 does not recur. Management targets a long-term growth algorithm where adjusted EBITDA grows at twice the rate of revenue, predicated on a return to 4-6% top-line growth by 2027. International business is projected to maintain high-teen year-over-year growth for 2026, though no acceleration in embassy processing is currently assumed. VMS and Locum tenens segments are expected to return to year-over-year growth in early 2027 as new client wins onboard and tech-enablement initiatives mature. Leverage is expected to remain at or below 2.0x through the remainder of the year, providing flexibility for capital allocation and potential M&A. Labor disruption revenue contributed $722 million in Q1, a non-recurring windfall that significantly skewed consolidated metrics. Physician and Leadership margins were impacted by a 110 basis point drag from increased sales reserves booked during the quarter. Technology and Workforce Solutions revenue decl...

AMN Healthcare Services (AMN) came out with quarterly earnings of $2.1 per share, beating the Zacks Consensus Estimate of $1.6 per share. This compares to earnings of $0.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +30.98%. A quarter ago, it was expected that this health care staffing company would post earnings of $0.22 per share when it actually produced earnings of $0.22, delivering no surprise. Over the last four quarters, the company has surpassed consensus EPS estimates three times. AMN Healthcare, which belongs to the Zacks Business - Services industry, posted revenues of $1.38 billion for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 11.90%. This compares to year-ago revenues of $689.53 million. The company has topped consensus revenue estimates four times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. AMN Healthcare shares have added about 33.1% since the beginning of the year versus the S&P 500's gain of 7.6%. While AMN Healthcare has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for AMN Healthcare was favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock. So, the shares are expected to outperform the market in the near future. You can see the complete list of today's Za...

Quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million; GAAP income of $1.59/share and adjusted EPS of $2.10 DALLAS, May 07, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2026 financial results. Financial highlights are as follows: Dollars in millions, except per share amounts. * See “Non-GAAP Measures” below for a discussion of our use of non-GAAP items and the table entitled “Non-GAAP Reconciliation Tables” for a reconciliation of non-GAAP items. Business Highlights First quarter revenue and earnings exceeded guidance with labor disruption, travel nurse, allied, and international nurse exceeding expectations. Travel nursing volume and revenue grew year over year for the first time since 2022. Allied, schools, international nurse, and search also delivered year-over-year revenue growth. Cash flow from operations of $562 million and our quarter-end cash balance of $561 million benefited from favorable timing of working capital related to recent labor disruption events. We ended the quarter with $750 million of debt, an undrawn revolving credit facility and a leverage ratio, calculated under the terms of our credit agreement, of 1.6x. “Our first quarter performance demonstrated strong execution across AMN, with results exceeding our expectations and guidance while navigating a dynamic market environment,” said Cary Grace, President and Chief Executive Officer of AMN Healthcare. “We delivered solid underlying growth in Nurse and Allied Solutions, saw momentum return in international staffing and search, and continued to advance our technology-enabled workforce solutions. The AMN team did an outstanding job supporting our clients and healthcare professionals, demonstrating the power of our enhanced technology platform and solutions to deliver at our highest level since the pandemic.” First Quarter 2026 Results Consolidated revenue for the quarter was $1.378 billion, a 100% increase from prior year and an 84% increase from the prior quarter. Net income was $62 million (4.5% of revenue), or $1.59 per diluted share, compared with net loss of $1 million (0.2% of revenue), or ($0.03) per diluted share in the first quarter of 2025. Adjusted diluted EPS in the first quarter was $2.10 compared...